If you have started reading about endocrine disruptors, you have probably already found the two versions of this story.
In the first version, invisible chemicals in your water bottle, your shampoo and your dinner are quietly destroying human fertility, and you should be frightened.
In the second, it is all overblown, the doses are tiny, and you should ignore it.
Well, neither version is honest.
The truth is more interesting and, in some ways, more useful: there is real, serious science proof here, and the strength of that science varies enormously depending on which chemical you are asking about. And the good news is – there are a handful of genuinely evidence-based things you can do without reorganising your entire life around fear.
This article is an attempt to give you the honest middle.
It covers what endocrine disruptors are, how they affect female and male fertility, where the evidence is strong and where it is still under research and studies, and the most useful info on what actually reduces your exposure.
What endocrine disruptors actually are
Your endocrine system runs on hormones, chemical messengers that travel through the blood and attach to receptors on target cells, rather like a key fitting a lock. Estrogen, testosterone, thyroid hormone, FSH and LH all work this way, and reproduction depends almost entirely on this signalling being precise.
An endocrine-disrupting chemical, usually shortened to EDC, is an external substance that interferes with that signalling. The Endocrine Society, which has published two major scientific statements on this topic, describes how these chemicals can mimic a natural hormone, block a receptor so the real hormone cannot bind, or alter how much of a hormone your body produces or clears.
Three features make EDCs behave differently from classical toxins, and they explain a lot of the confusion in this field.
Timing can matter more than dose. There are developmental windows, particularly in the womb, and again during puberty, when the reproductive system is being built and is far more sensitive to hormonal interference than it will ever be again. The same exposure can be trivial for an adult and consequential for a fetus.
The dose-response curve is not always a straight line. With most poisons, more is worse in a predictable way. Some EDCs behave non-monotonically, meaning a low dose can produce an effect that a higher dose does not. This is biologically plausible, because hormone systems themselves work this way, but it makes standard toxicology testing a poor fit.
You are never exposed to one chemical at a time. Real life is a mixture. Researchers increasingly study combined exposure rather than single compounds, because the sum can behave differently from the parts.
Where you actually meet them
Exposure is not exotic. The main routes are ordinary: food and its packaging, particularly tinned food and plastic containers; personal care products such as fragrances, preservatives and sunscreens; household dust, which accumulates chemicals shed from furniture, electronics and flooring; drinking water; thermal paper receipts; and, for some people, occupational contact in agriculture, manufacturing or hairdressing.
This is worth saying plainly, because people often read an article like this and conclude they have done something wrong. You have not. These chemicals are in the built environment of essentially every industrialised country. Nobody opted in.
Endocrine disruptors and male fertility
Male reproductive health is where this field began, and where the debate is loudest.
The sperm count question
The best-known finding is a large meta-analysis by Levine, Swan and colleagues, published in Human Reproduction Update in 2023, which pooled 223 studies and reported that sperm concentration fell substantially between 1973 and 2018, with the rate of decline appearing to accelerate after the year 2000. Unlike the team’s earlier analysis, this one found the pattern on every continent studied.
Here is the part that rarely survives the journey into a headline: this remains genuinely contested among reproductive scientists. Critics have argued that the samples are not representative across decades, that laboratory counting methods changed over the period in ways that could bias comparisons, and that natural variability between populations may be misread as a downward trend. A separate meta-regression using comparable methods did not reproduce the finding for every measure.
So the honest summary is: a real signal that most researchers take seriously, with an unresolved argument about its size and its causes. Attributing it specifically to endocrine disruptors is a further step that the data do not fully support on their own.
Where the male evidence is stronger
The more solid ground is anti-androgenic chemicals, substances that interfere with testosterone signalling. Phthalates, the plasticisers found in flexible plastics and fragranced products, are the most studied. In animals, prenatal phthalate exposure produces a consistent cluster of effects on the developing male reproductive tract.
In humans, prenatal exposure has been associated with subtle changes in markers of androgen action in male infants, and adult exposure has been associated with poorer semen parameters and higher sperm DNA fragmentation across multiple studies.
Heavy metals with endocrine activity, particularly lead and cadmium, and certain pesticide classes show reasonably consistent associations with reduced sperm concentration and motility, most clearly in occupationally exposed men.
Endocrine disruptors and female fertility
The female side of this research is younger but moving quickly, and it matters just as much.
Ovarian reserve and ovarian function
PFAS, or the “forever chemicals” used in non-stick coatings, water-repellent textiles and grease-resistant packaging, have become the most active area of study. A 2026 review in F&S Reviews synthesising evidence from 2023 onwards reports that PFAS cross physiological barriers and are repeatedly detected in follicular fluid, placental tissue, cord blood and breast milk, and that across cohorts they are associated with markers of impaired ovarian function and with poorer performance in assisted reproduction, including reduced normal fertilisation and blastocyst formation. A 2025 case-control study in Human Reproduction Open examined newer PFAS compounds in relation to premature ovarian insufficiency – a reminder that replacement chemicals are not automatically safer than the ones they replaced.
IVF outcomes
Some of the most directly relevant human data come from the EARTH study, a long-running prospective cohort at Harvard following couples through fertility treatment. In one analysis, published in Environmental Health Perspectives, higher urinary concentrations of certain phthalate metabolites in women were associated with fewer oocytes retrieved and lower rates of clinical pregnancy and live birth across IVF cycles.
That is a meaningful finding, and it deserves an equally honest caveat: not every study has reproduced it, and observational cohorts cannot fully separate chemical exposure from the lifestyle patterns that accompany it.
Gynaecological conditions
There is moderate evidence linking certain phthalate metabolites to endometriosis, and a growing but inconsistent literature on bisphenols and PCOS. These are associations rather than established causes, and both conditions have complex, multifactorial origins.
Microplastics: the newest chapter, and how to read it
Microplastics deserve their own section, because this is where the gap between what is published and what is understood is widest.
In 2024, researchers reported in Toxicological Sciences that they had detected microplastics in every human testis sample they analysed, at concentrations roughly three times higher than in the dog testes they examined alongside. In 2025, a Spanish team presented findings at the ESHRE annual meeting showing microplastics in around two-thirds of follicular fluid samples and just over half of seminal fluid samples from patients at a fertility clinic.
These are striking results, and they were reported worldwide as evidence that plastic is damaging fertility. That is not what they show. Detection is not damage. The testis study’s own authors were explicit that the correlations they observed do not imply causation, and the ESHRE work was a conference abstract that had not been through full peer review at the time it made headlines.
There is a further wrinkle that almost nobody reported. A group of scientists published a formal comment in the same journal challenging whether the analytical method used could reliably support the quantities claimed, and the original authors published a response defending their approach. Both sides agree the research question is important. They disagree about what the measurements mean. Note also that this critique was funded by a chemical industry body, which is context worth having rather than grounds for dismissing it.
That exchange is a good model for how to hold this whole topic: take it seriously, follow it, and resist the urge to convert an early finding into a settled fact.
Why this evidence is harder to read than the headlines suggest
Four methodological problems run through almost all human research on endocrine disruptors, and understanding them will make you a much better reader of the next scary article you encounter.
Many of the most-discussed compounds, including bisphenols and phthalates, leave the body within hours to days. A single urine sample therefore captures what someone was exposed to very recently, not their long-term average. This mismeasurement usually makes real effects harder to detect, not easier, meaning some studies may understate associations.
People with higher chemical exposure often differ in other ways too: diet, income, occupation, body composition, smoking. Good studies adjust for these, but adjustment is never perfect.
Reverse causation is a live possibility in cross-sectional work. And a great deal of the most alarming evidence comes from animals given doses and delivery routes that do not correspond to ordinary human exposure.
None of this means the concern is invented. It means the appropriate response is proportionate caution rather than either panic or dismissal.
| Chemical group | Main everyday sources | How strong is the human fertility evidence? |
| Phthalates | Flexible plastics, fragrance, food packaging | Moderate to strong, for both sexes |
| PFAS | Non-stick coatings, water-repellent fabric, some packaging, drinking water | Moderate and strengthening, strongest for female ovarian function |
| Bisphenols (BPA, BPS) | Tin linings, some plastics, thermal receipts | Moderate but genuinely disputed between regulators |
| Heavy metals (lead, cadmium) | Contaminated water and food, occupational exposure | Moderate, clearest in occupational settings |
| Pesticides | Food residues, agricultural work | Moderate for occupational exposure, weaker for dietary |
| Microplastics | Ubiquitous | Early – detection confirmed, effects on fertility not established |
What regulators are doing, and why they disagree
Bisphenol A is the clearest illustration of how unsettled this field remains at the highest level.
In 2023, the European Food Safety Authority published a re-evaluation of BPA that lowered the tolerable daily intake dramatically, by a factor of roughly twenty thousand compared with its previous provisional figure, and concluded that typical dietary exposure across all age groups exceeds that level. The EU subsequently moved to ban BPA in food contact materials, with the relevant regulation entering into force in January 2025.
Meanwhile the US Food and Drug Administration continues to consider BPA safe at current exposure levels, and Germany’s national risk assessment body publicly disagreed with EFSA’s conclusion.
Three competent scientific bodies, the same evidence, three different answers. This is not a scandal; it reflects real disagreement about how much weight to give academic low-dose studies versus standardised regulatory toxicology. But it should temper anyone’s confidence in either direction.
Professional bodies have been less equivocal about the general principle. The International Federation of Gynecology and Obstetrics issued an opinion on toxic environmental chemicals and reproductive health endorsed by the American Society for Reproductive Medicine, the European Society of Human Reproduction and Embryology and the Endocrine Society, and updated its guidance in 2025. Their consistent recommendation is that clinicians should discuss environmental exposure with patients as part of routine reproductive care.
Image source and ownership: bcpp.org
What actually reduces your exposure
Here is the genuinely encouraging part, and it is the finding least likely to appear in a frightening article: for the non-persistent chemicals, exposure responds quickly to what you do.
In a study published in Environmental Health Perspectives, researchers gave families three days of fresh, unpackaged meals with no tinned food and no plastic contact, storing everything in glass and stainless steel. Average urinary BPA fell by about two thirds and DEHP metabolites by roughly half. When participants returned to their usual diet, levels climbed back.
Your body is not accumulating these particular compounds indefinitely. It is continuously clearing them and you are continuously topping them up. Reduce the input and the level drops within days.
What that translates to in practice:
- Choose fresh and unpackaged food where you reasonably can, and reduce tinned food in particular, since tin linings are a significant BPA source.
- Store and reheat food in glass or stainless steel rather than plastic, and never microwave food in a plastic container, as heat substantially increases what migrates out.
- Choose fragrance-free personal care products where possible, since “fragrance” on a label can conceal phthalates.
- Filter your drinking water if PFAS contamination is a known issue where you live.
- Ventilate your home and damp-dust regularly, because household dust is a genuine exposure route.
- Handle thermal paper receipts less, and wash your hands afterwards.
- If your work involves regular contact with pesticides, solvents or industrial chemicals, raise it with your doctor before trying to conceive.
Note how ordinary all of that is. No special products, no expense, nothing that requires you to be frightened.
What does not work
Be sceptical of anything sold as a “detox” for endocrine disruptors, and of chelation therapy offered outside the narrow medical context of diagnosed acute heavy metal poisoning.
For the fast-clearing compounds, your body already does this efficiently. That is precisely why the dietary study above worked so quickly. For the persistent ones like PFAS, no supplement has been shown to meaningfully accelerate clearance. A small industry has grown up around fertility anxiety, and some of it explicitly cites the microplastics research discussed above. Reducing what goes in is the intervention with evidence behind it.
Keeping this in proportion
If you are trying to conceive, it is worth being clear about where this sits among the things that affect your chances.
Age, body composition, smoking, alcohol, underlying conditions such as endometriosis or PCOS, and, for men, factors like varicocele, all have larger and better-established effects on fertility than everyday chemical exposure does. If reducing endocrine disruptor exposure is displacing attention from any of those, the priorities are the wrong way round.
Nor should anyone reading this conclude that their difficulty conceiving was caused by their shampoo or their food storage. The evidence does not support that inference at an individual level, and it is not a burden anyone needs to carry.
What the evidence does support is that reducing exposure is sensible, cheap and low-risk, particularly in the months before conception and during pregnancy, and that it is one of the few things in a fertility journey that is entirely within your own control. That is a reasonable place to land.
This is worth knowing whoever you are
One last thought, because this topic is often written as though it only concerns heterosexual couples trying naturally.
If you are preparing for IVF, the exposure window that matters includes the months of oocyte and sperm development before your cycle begins. If you are freezing eggs or sperm, the same applies. If you are a gay couple working with an egg donor and a surrogate, or a lesbian couple where one partner will provide the eggs and the other will carry, or a single parent by choice using donor gametes, then this information is relevant to everyone whose body is contributing to the process, which may be several people rather than two.
It is a small point, but it matters: environmental exposure is a shared consideration across every path to parenthood, not just one of them.
Understanding your options is part of the journey
Environmental exposure is only one small piece of a much larger picture. Whatever path you are on – IVF, donor conception, surrogacy, or simply starting to understand your own fertility, the difference between feeling lost and feeling in control usually comes down to how well you understand what is actually happening and what your choices really are.
That is what our courses are built for. Created with fertility specialists, embryologists, lawyers and psychologists from around the world, they are designed to give you clear, honest information without judgement, whoever you are and however you are building your family.
Explore our courses and take the next step with confidence.
This article is for educational purposes and reflects the state of published research at the time of writing. It is not a substitute for personalised medical advice. If you have concerns about your fertility or about occupational or environmental exposure, please speak with a qualified healthcare professional.
Related articles
Common Myths Surrounding the IVF Lab and What the Science Actually Says in 2026
What Every Fertility Patient Should Know About the New Era of Prenatal Screening
How Artificial Intelligence Is Revolutionizing Fertility and Reproductive Medicine
